Safety profile of clobazam in the real world: an analysis of FAERS database and systematic review of case reports-Reference-Cited by-同舟云学术

Safety profile of clobazam in the real world: an analysis of FAERS database and systematic review of case reports

Published:2023-04-19 Issue: Volume: Page:1-10
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

An Pengjiao¹²^ORCID,Liu Xin¹²,Zhang Bo¹²

Affiliation:

1. Department of Pharmacy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

2. State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Beijing, China

Funder

National High Level Hospital Clinical Research Funding

CAMS Innovation Fund for Medical Sciences

Fundamental Research Funds for the Central Universities

Youth Research Fund of Peking Union Medical College Hospital

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2023.2204227

Reference44 articles.

1. Clobazam

2. LABEL: CLOBAZAM- clobazam tablet 2022 [updated 2021-Sep-25]. Available from: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=721dde68-db83-4dad-8649-8046cb455372#section-12

3. Product monograph including patient medication information: fRISIUM®clobazam 2022 [updated 2015-6-15]. Available from: https://pdf.hres.ca/dpd_pm/00030962.PDF

4. Clobazam and Its Use in Epilepsy

5. Pharmacovigilance‐based drug repurposing: The search for inverse signals via OpenVigil identifies putative drugs against viral respiratory infections

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The real-world safety of sacubitril / valsartan among older adults (≥75): A pharmacovigilance study from the FDA data;International Journal of Cardiology;2024-02